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Abstract
During an immune response T cells enter memory fate determination, a program that divides them into two main
populations: effector memory and central memory T cells. Since in many systems protection appears to be preferentially
mediated by T cells of the central memory it is important to understand when and how fate determination takes place. To
date, cell intrinsic molecular events that determine their differentiation remains unclear. MicroRNAs are a class of small,
evolutionarily conserved RNA molecules that negatively regulate gene expression, causing translational repression and/or
messenger RNA degradation. Here, using an in vitro system where activated CD8 T cells driven by IL-2 or IL-15 become
either effector memory or central memory cells, we assessed the role of microRNAs in memory T cell fate determination. We
found that fate determination to central memory T cells is under the balancing effects of a discrete number of microRNAs
including miR-150, miR-155 and the let-7 family. Based on miR-150 a new target, KChIP.1 (K
+ channel interacting protein 1),
was uncovered, which is specifically upregulated in developing central memory CD8 T cells. Our studies indicate that cell
fate determination such as surface phenotype and self-renewal may be decided at the pre-effector stage on the basis of the
balancing effects of a discrete number of microRNAs. These results may have implications for the development of T cell
vaccines and T cell-based adoptive therapies.
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Introduction
The defense against pathogens and cancer requires T cell
immunity. T cells see antigen presented in association to molecules
oftheMajorHistocompatibilityComplex(MHC)onspecializedcells,
dendritic cells, macrophages and B cells. Their activation requires an
additional signal from costimulatory molecules. Once T cell
recognition initiates, the primary T cell response follows temporal
characteristics that are well understood. Presumably through
symmetric cell division T cells expand clonally for about 7 days in
a way that is proportional to the antigen dose [1], and then contract
through a program that is independentof the magnitude ofexpansion
[2]. During the contraction phase the majority (90–95%) of effector T
cells die by apoptosis. One view is that memory T cells are generated
at this time, even though the events are not entirely understood. An
alternativeviewisthatmemoryTcellsoriginatedirectlyfromnaı ¨ve T
cells that undergo asymmetric cell division after prolonged contact
with the antigen presenting cell [3]. It is assumed that in both
instances memory T cells perpetuate thereafter either through self-
renewal, a stem-cell like property, or by homeostatic proliferation.
From the outset, memory T cells enter a fate determination
program that divides them into two main populations on the basis of
surface phenotype: effector memory(CD44
+/CD62L
low-nil/CCR7
nil)
and central memory (CD44
+/CD62L
hi/CCR7
hi)Tc e l l s .T h e s et w o
lineages have distinct homing characteristics and functional proper-
ties. Studies in humans suggest that effector memory and central
memory T cells form two independent populations [4]. In contrast,
studies in the mouse suggest that they may be part of a linear
developmental program where effector memory cellscan convertinto
central memory cells [5]. Since in many systemsprotection appears to
be preferentially mediated by T cells of the central memory type
[6,7,8,9], it is important to understand when and how lineage
differentiation begins (the lineage differentiation problem). Resolving
this issue has direct implications for vaccine design.
In past years studies to resolve the lineage differentiation
problem have underscored the importance of antigen dose, the
degree of inflammation at the time of priming, and the frequency
of naı ¨ve precursors [10]. Efforts to deconvolute in molecular terms
fate determination in memory T cells have been pursued
independently through micro-array gene profiling [11,12]. Studies
in the mouse have concluded that antigen specific CD8 T cells
acquire memory properties several weeks after antigen clearance,
suggesting that memory T cells arise from effector cells. This is in
line with T cell marking experiments that found that memory T
cells derive from effector T cells [13,14,15]. However, gene
profiling has not been able to identify a precise time or a set of
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determination of effector memory and central memory T cells.
MicroRNAs are a class of small, evolutionarily conserved, RNA
molecules that negatively regulate gene expression, causing transla-
tional repression and/or messenger RNA degradation [16,17].
MicroRNAs have been implicated in the control of many
fundamental cellular and physiological processes, directly or indirectly
[18]. Studies comparing naı ¨ve, effector and memory CD8 T cells,
show that a small set of microRNAs is downregulated in effector T
cells compared to naive cells, but also that expression tends to come
back in memory T cells [19]. However, direct comparison between
the effector memory and central memory subsets has not been
performed. Here we used microRNA analysis to verify if regulation at
this level is involved in memory T cell fate determination. To better
control the temporal dynamics of memory generation, we used an in
vitro system of effector memory/central memory CD8 T cell
differentiation where naı ¨ve T cells move from antigen activation into
fate determination on the basis of cytokine selection in culture
(Figure 1, A). CD8 T cells exiting in vitro education with IL-2 or IL-15
acquire the migratory and functional properties characteristic of
effector memory and central memory CD8 T cells generated in vivo
[20,21]. Here, we profiled microRNAs of IL-2 and IL-15 derived
memory CD8 T cells in an attempt to identify variations in expression
associated with the tempo of cell fate determination.
Results
Memory Lineage Differentiation in TCR transgenic T cells
of different specificity
We used an in vitro system to establish the generation of effector
memory and central memory CD8 T cells starting from naive
TCR transgenic CD8 T cells [20]. To minimize potential bias we
Figure 1. Model and phenotypic analysis of in vitro generated F5 and OT-I memory CD8 T cells. (A) Experimental model to study fate
determination of memory CD8 T cells. Spleens from naı ¨ve F5 or OT-I transgenic mice were harvested and cultured with LPS blasts, activated dendritic
cells (DC), pulsed with peptide (NP366–374 for F5 or Ova257–264 for OT-I T cells). After 48 hrs, LPS blasts were removed and activated cells were re-
cultured with either IL-15 (40 ng/mL) or IL-2 (40 ng/mL). Every 48 hrs the media was replenished with fresh cytokines at 20 ng/mL. (B–C) Expression
of CD44 (IM7) and CD62L (MEL-14) on naive and day-8 IL-15- or IL-2-derived F5 or OT-I CD8 T cells using anti-mouse CD44-PE and rat anti-mouse
CD62L-APC. Cells were stained with 7-ADD (7-AAD PerCP) to identify dead cells, then gated on CD8 T cells. Each histogram represents the analysis of
10,000 7-ADD-negative CD8 T cells. (D–F) Expression of CD25 (PC61), CD45R (B220), CD43 (IB11) and CD62L (MEL-14) on naı ¨ve and day-8 IL-15- or IL-2-
derived F5 Tg CD8+ T cells. Numbers represent percentage of cells in the respective quadrants. (G) Expression of CCR7 (4B12) on naı ¨ve and day-8 IL-
15- or IL-2-derived F5 CD8 T cells. Filled histograms = isotype (rat IgG2a) staining; solid black line=CCR7 staining.
doi:10.1371/journal.pone.0011243.g001
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cells from RAG 2/2 F5 transgenic mice (F5) that are specific for
the ASNENMDAM peptide of the nucleoprotein (NP) antigen of
the influenza A virus [22], and CD8 T cells from OT-I mice
specific for the SIINFEKL peptide of ovalbumin [23]. We
reasoned that microRNA expression levels that are truly associated
with the process of cell fate determination of memory T cells
would be shared by T cells with distinct TCR specificities.
Activation of naı ¨ve F5 and OTI CD8 T cells followed by in vitro
culture either in IL-2 or IL-15 (Fig. 1, A) yields memory T cells
with effector memory (CD44
hi/CD62L
lo/nil) or central memory
(CD44
hi/CD62L
hi) characteristics by day 8, that is six days after
cytokine-directed memory lineage differentiation. Detailed surface
phenotype analysis of day 8 memory T cells showed that IL-15-
derived memory T cells are in addition CD25 intermediate,
CD45R (B220)
lo, CD43
lo and CCR7
+. In contrast IL-2-derived
memory T cells are CD25
hi, CD45
int/hi, CD43
hi and CCR7
2.A
phenotypic analysis of OT-I cells showed comparable results on
day 8. Interestingly, a comparison of the tempo of central memory
T cell generation in F5 and OT-I cells showed consistently that
whereas the percentage of CD44
hi/CD62L
hi OT-I cells increases
progressively through day 8, the percentage of CD44
hi/CD62
hi F5
cells is maximal at day 4 and decreases thereafter (Figure S1). This
suggests different modalities in the generation of the central
memory phenotype, possibly reflecting different avidity of either
the TCR or the peptides for the MHC.
MicroRNA Analysis of IL-2 and IL-15 directed CD8
memory T cell fate determination
We identified the microRNAs differentially expressed upon IL-2
and IL-15 treatment by using paired t-test for each experimental
time point. Prior to t-test, microRNA datasets were quantile-
normalized and the invariant microRNAs removed. A microRNA
was considered statistically significant if its t-test p value was
,0.05. False detection rates helped to control for multiple testing.
Six independent experiments were performed, three with F5 T
cells and three with OT-I T cells, and total RNAs were collected
on day 0, 2, 4, 6 and 8. We measured the changes in microRNA
profile after treatment with IL-2 or IL-15 and found different
microRNA profiles for IL-15 (Figure S2,A) and IL-2 (Figure S2,B),
respectively. We then combined the effect of the two treatments
into a single clustering tree (Fig. 2) representing the log2 ratios of
mean IL15/IL2 expression at each time point for the significant
microRNAs. The expression at days 4, 6 and 8 was measured
relative to the baseline values (day 0 and 2). We noted that
differentiation in the presence of IL-15 induced a differential
increase of miR-150 (red squares) and a decrease of miR-155. In
converse, differentiation in the presence of IL-2 down-modulated
(green squares) miR-150 and miR-146, albeit the effect on miR-
146 was late. Of note, we found that members of the let-7 family
Figure 2. MicroRNA expression analysis in fate determination
of central and effector memory CD8 T cells. Clustering tree
representation of differences in microRNA expression between effector
memory and central memory CD8 T cells. Total RNA was extracted from
cells at different time points for either IL-15 or IL-2 treatments. Samples
were run in triplicate. Six independent experiments were performed,
three with F5 and three with OTI CD8 T cells. Cluster and TreeView were
used to plot the log2 IL-15/IL-2 expression ratios. Red square means
higher miR-NA expression upon IL-15 (IL-15/IL-2.1) and green squares
mean higher miR-NA expression upon IL-2 treatment (IL-2/IL-15.1).
The values are log2 ratios, i.e. 0 (black) means the fold change (or ratio)
between IL-15 and IL-2 signals is 1 (no difference).
doi:10.1371/journal.pone.0011243.g002
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in IL-15 treated T cells (Fig. 2 and Figure S2,A).
Expression of miR-150 and miR-155 in central memory T
cells by qPCR
The miRNA array data reflected the average of six independent
experiments and included, as noted above, two different types of
TCR transgenic T cells. The expression of miR-150 and miR-155
in the IL-15-directed differentiation of central memory T cells was
verified by qPCR using day-2 values as the baseline reference. We
reasoned that any meaningful variation would exclude the broad
variations in microRNA expression due to T cell activation. miR-
150 was elevated in both F5 and OT-I IL-15-derived memory T
cells. The increased expression was immediate and persisted
through day 8 (Fig. 3,A). The increase in expression was similar in
F5 and OT-I T cells. Similarly, the decreased expression of miR-
155 was confirmed both in F5 and OT-I cells (Fig. 3,B). The
decrease was progressive and maximal at day 8, consistent with the
array data. To see if these variations in miRNA expression were
specific and, more importantly, could be modulated, experiments
were repeated where activated T cells were transfected with
inhibitory (anti-)miR-150 or stimulatory (pre-)miR-155 precursors
on day 2 before culture with IL-15. Transfection with (anti-)miR-
150 inhibited the increased expression of miR-150 by 40%
(Fig. 3,C). On the other hand, transfection with (pre-)miR-155
caused a dramatic upregulation of miR-155 expression at all time
points (Fig. 3,D). Collectively, the data suggest that during the
generation of central memory CD8 T cells two microRNAs, miR-
150 and miR-155, may play a reciprocal non-static role in the
progression of CD8 T cells to central memory phenotype.
Target prediction uncovers a new gene in the
differentiation of central memory CD8 T cells
MicroRNAs exert transcriptional/post transcriptional gene
expression regulation through binding to partially complementary
sites in the 30-untranslated region of target genes. We used PicTar
[24], a target prediction algorithm, to identify the potential targets
for miR-150 and miR-155 with a prima facie relation to T
lymphocytes. These predictions are plotted along the trajectories
of IL-15 and IL-2-directed memory T cell generation (Fig. 4).
miR-150 predicts two targets, KChIP.1 (K
+ channel interacting
protein 1) and c-Myb. KChIP.1, a member of a family of Ca
++
-binding protein that binds to the intracellular N-terminal domain
of A-type potassium channels [25], and is expressed in T
lymphocytes where it represses IL-2, IL-4 and IFNc production
during antigen specific activation [26]. KChIP.1 was readily and
highly up-regulated in both F5 and OT-I IL-15-directed memory
T cells (maximal amplification=150-fold in F5 T cells and
.1000-fold in OT-I cells when compared to the respective day-2
baseline value). KChIP.1 up-regulation appeared to be specific for
central memory T cell differentiation since no up-regulation
occurred when memory T cells were generated with low dose IL-2,
Figure 3. Levels of miR-150 and miR-155 expression in central memory CD8 T cells by qPCR. Fold modulation in F5 (A) and OT-I (B) IL-15-
derived memory CD8 T cells. Total RNA was extracted from triplicate cultures on day 0, 2, 4, 6 and 8, and subjected to microRNA-specific reverse
transcription (RT) followed by qPCR for miR-150 and miR-155 with snoRNA202 as endogenous control. Data points refer to the mean 6 SD of a
combined experiment with F5 and OT-I T cells and are representative of two independent experiments for F5 and OT-I T cells, respectively. (C)
Decrease in miR-150 expression by the inhibitory microRNA precursor (anti)miR-150 (ABI AM150). Briefly, day-2 peptide-activated CD8 T cells were
transfected with AM150 (150 nM) and cultured as indicated in Materials and Methods. On day 4, 6 and 8, cells were harvested, total RNA extracted,
and levels of miR-150 expression measured by qPCR and compared with day-2 baseline values. Representative of two independent experiments.
Tests were done in triplicate. (D) Reversal of miR-155 expression levels in central memory T cells by the stimulatory microRNA precursor (pre)miR-155
(ABI PM155). Day-2 peptide-activated CD8 T cells were transfected with PM155 (150 nM). Cells were then cultured, harvested, and the RNA tested as
indicated above. Data point refers to the combined mean 6 SD of two independent experiments with F5 and OT-I T cells, respectively. Tests were
done in triplicate.
doi:10.1371/journal.pone.0011243.g003
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significance remains unclear. c-Myb is a key transcription factor in
lymphocyte development. In the development of B cells a miR-
150/c-Myb partnership has already been demonstrated [27,28].
Furthermore, c-Myb has been shown to play a role in the
development of thymocytes but also in the proliferative response of
mature T cells [29]. Here, c-Myb was up-regulated in both F5 Tg
and OT-I IL-15-derived memory T cells. While there was no c-
Myb up-regulation in IL-2-derived OT-I cells, F5 T cells showed
up-regulation on average 2-fold lower than their IL-15 counter-
part (Fig. 5,A and B). Previously it was shown that purified splenic
CD8T cells from c-Myb knock-out mice have a 3-fold greater
response to anti-CD3/anti-CD28 or IL-2 [29], implying regula-
tion of mature CD8 T cells by cMyb. Whereas the role of IL-15
was not investigated, our results provisionally suggest that c-Myb
plays a differential role in proliferation and fate determination of
memory CD8 T cells depending on whether they respond to IL-15
or IL-2. Further studies are needed to elucidate this issue.
Our model (Fig. 4,A) also predicts IL-7R to be a target of miR-155.
IL-7R is expressed on both central memory (CD62L
hi)a n de f f e c t o r
memory(CD62L
lo)CD8T cells.IL-7Rplaysacentralroleinpositive
selection in the thymus [30], and enhances the survival of mature T
cells including memory T cells [31]. However, whether it identifies
memory T cell precursors is still matter of debate. Relative
quantification shows a greater fold increase in central memory than
in effector memory T cells (Fig. 5,A and B), suggesting that IL-15
signaling is intrinsically more effective in dictating IL-7R expression.
This is consistent with the observed decreased level of miR-155 in
central memory T cells.
Anti-miR-150 modulates the central memory phenotype
We decided to verify whether the acquisition of a central memory
phenotype could be modulated by treating antigen-activated, day-2
CD8 T cells with the (anti)miR-150. F5 or OT-I T cells were
transfected with (anti)miR-150, cultured in the presence of IL-15 and
harvested every 2 days. A marked effect was noted in OT-I cells on
day 4 where down-modulation of miR-150 was followed by an
increase in the percentage of central memory T cells ,30%
(392.54%) (Fig. 4,B). The positive effect on the percentage of cells
with central memory phenotype was maintained through day 8,
albeitat a smaller magnitude. The effect on F5 T cells was overallless
pronounced ,10% increase (752.82%), which is explained by the
different kinetics between F5 and OT-I cells (Figure S1). Combined
with the prediction that miR-150 negatively regulates KChiP.1, these
results suggest that miR150 exerts negative feedback regulation on
the acquisition of a central memory phenotype by antigen-activated
CD8 T cells cultured in IL-15.
Discussion
We show that the differentiation of antigen-activated CD8 T
cells into memory phenotypes through IL-15 or IL-2 signaling is
subject to regulation by a limited number of microRNAs (Fig. 4,A).
This is surprising in light of (a) the complex and still little
understood transcriptional programs that drive fate determination
in memory T cells, and (b) the fact that IL-15 and IL-2 impart
signals to antigen-activated T cells through the common IL-2/IL-
15 receptor bc chain.
A first important consideration from our analysis is that the
separate fate of central memory and effector memory T cells
dictated by cytokine signaling is under coordinated regulation by a
discrete number of microRNAs. Since IL-15 and IL-2 signal
through a common receptor, it would appear that intensity rather
than quality of signal determines regulation by miR-150 and miR-
155 in activated CD8 T cells destined to acquire central memory
T cell characteristics. Complex transcriptional events must take
place to orchestrate repression of proliferation in CD8 T cells
committed to central memory fate determination through IL-15.
By comparing F5 and OT-I T cells it appears that the central
memory phenotype is acquired within 48 hrs from discontinuing
contact with antigen, and it stabilizes over the following days
(Figure S1). They also show that different transgenic T cells
undergo fate determination at a different pace, suggesting that in a
polyclonal population, lineage differentiation of memory CD8 T
cells may be a stochastic event.
A second important consideration underscored by this study is a
pattern of reciprocal regulation between miR-150 and miR-155 in
memory CD8 T cell fate determination. A reciprocal miR-150
low/
miR-155
high pattern of regulation was previously reported in B cell
chronic lymphocytic leukemia [32]. Both miRNAs have also been
linked to regulation of the immune response as demonstrated by
genetic deletion and transgenic approaches. Of interest, miR-150 is
suppressed upon T cell activation [33], underscoring the importance
of a differential increase in miR-150 along the trajectory of central
memory T cells (Fig. 4). In converse, miR-155, which is elevated in
activated T cells, decreases in central memory T cells. Taken
together, these lines of evidence suggest that a reciprocal miR-
150
high/miR-155
low regulation guides T cells along the central
memory trajectory. We see this as the effort of emerging memory T
cells to distance themselves from the activation state, rolling into a
maintenance state (self-renewal). This is consistent with the fact that
microRNAs of the let-7 family are down-regulated during IL-15-
drivencentralmemoryfatedetermination(Fig.2).Sinceadecrease in
expression of let-7, a family of microRNAs tightly regulated during
embryonic stem cell differentiation [34], enables self-renewal in
embryonic stem cells [35], it appears as if self-renewal in incipient
central memory T cells may result from a concomitant suppression of
the let-7 family of microRNAs.
A third and novel finding of this study is the identification of
KChIP.1 as a gene specifically transcribed during the differenti-
ation of activated CD8 T cells into central memory T cells (Fig. 5,
A and B). KChIP.1 belong to a family of Ca
2+ -binding proteins
that associate with the intra-cellular N-terminal domain of voltage-
gated K
+ channels [25]. Mouse T lymphocytes express two types
Figure 4. Effect of microRNAs in fate determination of memory CD8 T cells. (A) Model and findings. Memory T cell fate determination is
graphically represented as two trajectories originating from a common start point: the day-2 peptide-activated CD8 T cells. Identified on the
trajectories are the observed variations in miR-150 and miR-155 expression, and the target genes considered. qandQ refer to net increase/decrease
from the corresponding baseline values. D refers to a variation between IL-15-derived and IL-2-derived memory T cells at corresponding time points.
(B–C) Kinetics of phenotypic changes in central memory development originating from antigen-activated OT-I and F5 CD8 T cells with or without
(anti)miR-150. Spleens from naı ¨ve OT-I and F5 cells transgenic mice were harvested and cultured with DC pulsed with peptide (Ova257–264 for OT-I or
NP366–374 for F5). After 48 hrs, DC were removed and activated T cells were re-cultured with IL-15 (40 ng/mL). In parallel cultures CD8 T cells were
transfected with 150 nM of (anti)miR-150 as indicated in Materials and Methods. Every 48 hrs the media was replenished with fresh IL-15 (20 ng/mL).
Expression of CD44 (IM7) and CD62L (MEL-14) was detected using anti-mouse CD44-PE and rat anti-mouse CD62L-APC, respectively. Cells were
stained with 7-ADD (7-ADD PerCP) to identify dead cells, then gated on CD8 T cells. Each histogram represents the analysis of 10,000 7-ADD-negative
CD8 T cells. Numbers represent percentage of cells in the respective quadrants.
doi:10.1371/journal.pone.0011243.g004
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+ channels originally termed ‘‘n’’ (normal) and ‘‘l’’ (large) [36].
The latter is upregulated upon activation by mitogens. By analogy
with human K
+ channels, the activatable K
+ channel corresponds
to the calcium-activated K
+ channel (IKCa1) whose expression is
greatly increased upon protracted activation through the TCR
[37]. In contrast, the number of voltage-gated K
+ channels (e.g.,
Kv1.3) is upregulated to 1,500-2,000 channels/cell [38]. In
humans Kv1.3 is expressed in effector memory CD4 T cells,
whereas central memory CD4 T cells express IKCa1 [39]. Thus,
KChIP.1 transcriptional activation appears to hallmark a change
in K
+ channel expression in developing central memory T cells.
KChIPs are also related to the downstream regulatory element
antagonist modulator (DREAM), also a Ca
2+-dependent tran-
scriptional repressor expressed in the brain, thyroid gland and
thymus [40]. Transgenic mice expressing a cross-dominant active
DREAM and KChIPs show reduced T cell proliferation and
decreased IL-2 production after polyclonal activation or TCR
activation by antigen [26]. Thus, an elevated KChIP.1 in central
but not effector memory T cells could function as Ca
2+2
-dependent repressor of proliferation favoring self-renewal/
Figure 5. Expression of microRNA-predicted target genes by qPCR. Expression of KChIP.1, c-Myb and IL-7R was quantitated in total RNA
extracted from F5 (A) or OT-I (B) CD8 T cells cultured in IL-15 or IL-2. Reverse transcription was performed starting with the same amount of RNA
template to generate cDNA. KChIP.1 and IL-7R were amplified using custom-made probes and primer sets. c-Myb was amplified with ABI probes
Mm01188144_m1. Data are representative of two independent experiments with F5 and OT-I T cells each. Tests were done in triplicate.
doi:10.1371/journal.pone.0011243.g005
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secondary lymphoid organs until re-encounter with antigen. This
is consistent with the fact that fate determination is subject to
complex regulatory events involving miR-150 which has an early,
direct effect on KChIP.1 expression (Figure S3).
The emergence of central memory T cells after antigen
activation followed by IL-15 signaling suggests that the existence
of a highly responsive and regulatable transcriptional machinery.
IL-15 provides activated T cells with appropriate survival and
proliferation signals [41,42] and also prevents apoptosis [43]. Of
note, IL-15 added 48 hrs after activation by antigen has important
effects such as reduction of cell size, decrease in protein content
and synthesis, and less efficient maintenance of IL-2R levels when
compared with IL-2-directed memory T cell generation [44].
Since IL-15 (not IL-2) is associated with the transcriptional
activation of KChIP.1 in antigen-activated T cells, and the
elevated expression of KChIP.1 has been reported to restrain
proliferation and IL-2 production by in activated T cells [26], it
appears as if by lowering the metabolic demand of the cell and by
restraining IL-2 mediated proliferation, the coordinated action of
IL-15 and KChIP.1 prepares the cell for survival and self-renewal.
The present findings bear implications for the lineage differenti-
ation problem. We show that activation of naı ¨ve T cells without
effector stage differentiation suffices to set in motion the transcrip-
tional program leading to central memory fate determination, and
involves a discrete number of microRNAs. Arguably, regulation at
this early stage is effective since the T cell (a) has yet to switch on the
transcriptional program of the effector stage, and (b) needs not to deal
with the pro-apoptotic consequences of the contraction phase. This
view is at variance with the conclusion of T cell marking experiments
[13,14,15] where memory T cells are progeny of effector cells which
acquireself-renewal properties [45]. We posit instead that activated T
cells committed to a central memory fate (TCM precursors) activate a
program that enables the acquisition of central memory phenotype
through the balancing effects of miR-150/miR-155, and self-renewal
characteristics through a decrease expression of let-7 microRNAs, a
shared trait between embryonic stem cells and central memory T
cells. These effects are synergistic and not absolute, and depend on a
gradient effect similar to that observed for the transcription factor T-
bet whose restrained expression during low inflammatory conditions
is important to establish a memory CD8 T cell population [46]. Of
note, miR-146, which is involved in Th1/Th2 differentiation and is a
putative negative regulator of inflammatory conditions [47], was
found to be down-regulated late in effector but not central CD8 T
cells. Thus, our data suggest that cell fate determination in memory
CD8 T cells operates according to an expression gradient of specific
microRNAs. This does not exclude a synergy between microRNA
regulation and regulation by other transcription factors [48] found to
influence memory CD8 T cell emergence based on their relative
expression [49].
In conclusion, here we show a new aspect in the biology of
lineage differentiation of central memory CD8 T cells, regulation
by micro-RNAs in cell fate determination at the pre-effector stage.
The present findings are conceptually relevant for the design of
vaccination strategies to more effectively select for the induction of
protective central memory CD8 T cells [10].
Materials and Methods
Mice, synthetic peptides and immunological reagents
Eight wk old C57BL/6 mice were purchased from the Jackson
Laboratories. F5 RAG
2/2 TCR were obtained from the National
Institute of Health (Bethesda, MD) through the courtesy of Dr.
Jonathan Yewdell. OT-I C57BL/6 (Thy1.2
+) were maintained in the
animal facility of the University of California, San Diego. All animals
were handled in strict accordance with good animal practice as
defined by the relevant national and/or local animal welfare bodies,
and all animal work was performed based on approved protocol by
the Institutional Animal Subject Committee (UCSD No. S00023).
Influenza virus NP 366–374 peptide (ASNENMDAM) and Ova257–264
peptide (SIINFEKL) were synthesized at the Peptide Synthesis Core
Facility of Ohio State University. rIL-15 was purchased from R&D
and rIL-2 from eBioscience (San Diego, CA). Mitomycin-C and LPS
were purchased from Sigma.
Cell culture and transfection
LPS blast preparation. C57BL/6 spleens were harvested
and 4610
7 cells/flasks cultured with LPS at a final concentration
of 25 mg/ml plus dextran-sulfate at 0.7 mg/ml for 3 days. Peptide
pulsing of LPS blasts. LPS blasts were harvested, treated with
mitomycin- C (50 mg/ml) for 20 mins at 37uC, and pulse-labeled
with OVA257–264 peptide or NP 366–374 peptide at a final
concentration of 10 mg/ml for 1 h at 37uC in a water bath.
Co-culture of naı ¨ve TCR transgenic cells with peptide-
pulsed LPS. OT-I or F5 transgenic T cells were harvested and
cultured with peptide-pulsed LPS blasts at 1610
6 TCR transgenic
T cells/8610
6 LPS blasts per well (24-well plate) in 2 ml final
volume of complete RPMI (10% FBS, RPMI-1640, penicillin/
streptomycin, L-glutamine, NaPyr, NEAA, 2-ME, gentamicin and
HEPES). On day 2 after co-culturing, the cells were harvested,
dead cells removed using Lympholyte-M, and the remaining cells
resuspended at 1 ml/well of complete RPMI. rIL-15 or rIL-2 were
added at the final concentration of 40 ng/ml. Cells were
incubated at 37uCi n5 %C O 2 for 6 days. Fresh rIL-15/rIL-2
was added to cultures every 2 days at a final concentration of
20 ng/ml. On day 8, cells were harvested and aliquots prepared
for Flow cytometry analysis and miRNA extraction.
Transfection
After Lympholyte M, cells were resuspended in 428 ml/sample of
RPMI-1640 containing HEPES, L-glutamine, penicillin and strep-
tomycin and plated in a 24-well plate. Lipofectamine
TM transfection
was performed according to the manufacturer’s instructions. Briefly,
lipoplexes were prepared by combining 4 mlP l u s
TM reagents, 0.4 mg
of plasmid DNA, 15 ml of (anti/pre)miRs (150 nM final concentra-
tion) and 25 ml of Optimem media per sample and incubated for
15 min at room temperature. Anti-miR-150 and pre-miR-150 were
purchased from Applied Biosystem (Life Technologies, Carlsbad,
CA). Per manufacrturer’s specifications anti-miR
TM microRNA
inhibitors are chemically modified, single stranded nucleic acids
designed to specifically bind to and inhibit endogenous microRNA
molecules, whereas pre-miR
TM microRNA precursor molecules are
small,chemically modified double-stranded RNA molecules designed
to mimic endogenous mature microRNAs. This solution was mixed
with 2 ml of Lipofectamine in 25 ml of Optimem media. Lipoplexes
were then combined and further incubated for 15 mins at room
temperature. Following incubation, the DNA-miR-Plus
TM- Lipofec-
tamine
TM complexes were added to each well to a final volume of
500 ml. After 3 h incubation, media was removed and replaced with
2 mL of cRPMI and cytokine solution. Cytokines were replenished
every two days as previously stated and the cells harvested at each
point for analysis.
Flow Cytometry
Culture CD8 T cells were stained using the following
fluorochrome-conjugated anti-mouse antibodies: CD8 (Ly-2),
CD44 (IM7), CD62L (MEL-14), CD43 (IB11), CD45R (B220),
CD25 (PC61) and CCR7 (4B12). All antibodies were purchased
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7AAD negative (Calbiochem) and FITC-CD8
+ population.
Within the CD8+ viable cells, the central memory T cell
population was identified as APC-CD62L
hi/PE-CD44
hi and the
effector memory as APC-CD62L
low/PE-CD44
hi. Flow cytometry
was performed on a FACSCalibur (BD Biosciences, San Jose, CA).
Data were acquired using BD CellQuest Pro and analyzed using
FlowJo software (Tree Star, Ashland, OR).
MicroRNA array
MicroRNA array analysis was performed as follows. Briefly,
5 mg of total RNA were used for hybridization of miR-NA
microarray chips. These chips contain gene-specific oligonucleo-
tide probes, spotted by contacting technologies and covalently
attached to a polymeric matrix. The microarrays were hybridized
in 66 SSPE (0.9 M NaCl/60 mM NaH2PO4 ?H2O/8 mM
EDTA, pH 7.4)/30% formamide at 25uC for 18 hr, washed in
0.756TNT (Tris?HCl/NaCl/Tween 20) at 37uC for 40 min, and
processed by using a method of detection of the biotin-containing
transcripts by streptavidin-Alexa647 conjugate. Processed slides
were scanned using a microarray scanner (Axon), with the laser set
to 635 nm, at fixed PMT setting, and a scan resolution of 10 mm.
Microarray images were analyzed by using GenePix Pro and post-
processing was performed essentially as described earlier [50].
Briefly, average values of the replicate spots of each miR-NA were
background-subtracted and subject to further analysis. Micro-
RNAs were retained when present in at least 20% of samples and
when at least 20% of the miR-NA had fold change of more than
1.5 from the gene median. Absent calls were thresholded prior to
normalization and statistical analysis. Normalization was per-
formed by using the quantiles method. MicroRNA nomenclature
was according to the microRNA database at Sanger Center [51].
We identified genes that were differentially expressed among the
two IL-15 and IL2 classes using paired t-test. Data have been
deposited in a MIAME compliant database. The accession No.
will be provided as it becomes available.
Quantitative PCR (qPCR)
Total RNA was extracted from 4610
5 T cells with Applied
Biosystems (ABI) miR-VANA miR-NA Isolation Kit (#AM1560)
using the total RNA isolation procedure. Reverse transcription was
performed from 250 ng of total RNA using High Capacity cDNA
Reverse Transcription kit (ABI, 4368814) and 1 cycle at 25uC
10 min, 37uC1 2 0m i n ,8 5 uC5sa n d4 uC hold. Gene specific
primers mmu-miR-150#, mmu-miR-155 and snoRNA202 (ABI)
were utilized to generate cDNA for miR-150, miR-155 and
snoRNA202 (endogenous control). MicroRNAs were analyzed by
duplicate qPCR following ABI protocol for master mix. 5 uL
Taqman master mix, 0.5 uL probe, 1 uL cDNA and 3.5 uL water
for a total reaction volumeof 10 uL. Universal cycling conditions for
qPCR were utilized consisting of 1 cycle of 50uC 2 min, 95uC
10 min followed by 50 cycles at 95uC1 5s ,6 0 uC6 0s .T a q m a n
inventoried and validated probe and primer set for mmu-miR-150,
mmu-miR-155 and snoRNA202 were utilized for qPCR.
Supporting Information
Figure S1 Kinetics of phenotypic changes in central memory
development originating from antigen activated OT-I and F5 CD8 T
cells. Spleens from naı ¨ve OT-I and F5 cells transgenic mice were
harvested and cultured with LPS blasts pulsed with peptide (Ova257–
264 for OT-I or NP366–374 for F5). After 48 hrs, LPS blasts were
removed and activated cells were re-cultured with either IL-15
(40 ng/mL) or IL-2 (40 ng/mL). Every 48 hrs the media was
replenished with fresh cytokines at 20 ng/mL. Expression of CD44
(IM7) and CD62L (MEL-14) were detected using anti-mouse CD44-
PE and rat anti-mouse CD62L-APC. Cells were stained with 7-ADD
(7-ADD PerCP) to identify dead cells, then gated on CD8 T cells.
Each histogram represents the analysis of 10,000 7-ADD-negative
and CD8 T cells. Numbers on the histograms represent percentage of
cells in the respective quadrants.
Found at: doi:10.1371/journal.pone.0011243.s001 (0.29 MB TIF)
Figure S2 Time course of microRNA variations in fate
determination of memory CD8 T cells. (A) MicroRNA analysis of
memory CD8 T cells cultured in IL-15 after antigen priming. Total
RNA was extracted from cells at different time points after the
initiation (day2) of IL-15 treatment. Samples were run in triplicate.
Six independent experiments were performed, three with F5 and
three with OTI CD8 T cells. For each time point, day 4 (D4), day 6
(D6), day 8 (D8) of treatment Cluster and TreeView were used to
plot the log2 of fold changes relative to the control day 2 (D2). Red
square means higher miRNA expression upon IL-15 and green
squares mean lower miRNA expression upon IL-15 treatment.
Black squares mean no change in expression. (B) MicroRNA
analysis of memory CD8 T cells cultured in IL-2 after antigen
priming.TotalRNAwasextractedfromcellsatdifferenttimepoints
for IL-2 treatments. Six independent experiments were performed,
three with F5 and three withOTI CD8 T cells. For each time point,
day 4 day 4 (D4), day 6 (D6), day 8 (D8) of treatment Cluster and
TreeView were used to plot the l log2 of fold changes relative to the
control day 2 (D2). Red square means higher miRNA expression
upon IL-2 and green squares mean lower miRNA expression upon
IL-2 treatment. Black squares mean no change in expression.
Samples were run in triplicate.
Found at: doi:10.1371/journal.pone.0011243.s002 (0.26 MB TIF)
Figure S3 Anti-miR-150 accelerates the transcriptional activa-
tion of ChIP1 in celntral memory cells. Spleen cells from naı ¨ve
OT-I transgenic mice were cultured with LPS blasts pulsed with
peptide (Ova257–264). After 48 hrs, LPS blasts were removed and
activated cells were were transfected with AM150 (150 nM) and
cultured as indicated in Methods and further cultured with IL-15
(40 ng/mL). Two and six day later cells were harvested, the RNA
extracted and KChIP.1 amplified using custom-made probes and
primer set. Tests were done in triplicate.
Found at: doi:10.1371/journal.pone.0011243.s003 (0.12 MB TIF)
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